当前位置: X-MOL 学术Appl. Immunohistochem. Mol. Morphol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8)
Applied Immunohistochemistry & Molecular Morphology ( IF 1.3 ) Pub Date : 2020-01-31 , DOI: 10.1097/pai.0000000000000830
Haiyan Lu 1 , Daniela Allende 1 , Xiuli Liu 2 , Yaxia Zhang 1, 3
Affiliation  

Solid pseudopapillary neoplasms (SPNs) and pancreatic neuroendocrine tumors (PanNETs) are distinctive entities. However, due to overlapping morphologies, distinguishing them remains a diagnostic challenge. Our study investigates the utility of immunohistochemistry for nuclear lymphoid enhancer binding factor 1 (LEF1) and paired box gene 8 (PAX8) in differentiating these 2 entities. LEF1 and PAX8 immunohistochemistry were performed on fine-needle aspiration cell blocks and surgical resection specimens diagnosed as SPN or PanNET at our institution from January 2007 to August 2016. Eight SPN and 25 PanNET cell blocks and 17 SPN and 34 PanNET surgical resection specimens were examined. On cell blocks, positive staining for LEF1 had high frequency, sensitivity, and specificity for SPN (88%, 88%, and 88%) as did positive staining for PAX8 for PanNET (76%, 76%, and 75%). The findings on surgical resection specimens were consistent with those from cell blocks (LEF1+ in SPN: 100%, 100%, and 97%; PAX8+ in PanNET: 59%, 59%, and 100%). A combined LEF1+/PAX8− phenotype showed high sensitivity and specificity for SPN (cell block: 63% and 100%; surgical specimen: 100% and 98%) as did a LEF1−/PAX8+ phenotype for PanNET (cell block: 64% and 100%; surgical specimen: 59% and 100%). SPN and PanNET exhibit opposite immunophenotypic profiles with LEF1+/PAX8− in SPN and LEF1−/PAX8+ in PanNET. The combination of these 2 stains provides an effective means of distinguishing these 2 entities.

中文翻译:

淋巴增强子结合因子 1 (LEF1) 和配对盒基因 8 (PAX8)

实体假乳头状肿瘤 (SPNs) 和胰腺神经内分泌肿瘤 (PanNETs) 是不同的实体。然而,由于重叠的形态,区分它们仍然是一个诊断挑战。我们的研究调查了免疫组织化学对核淋巴增强子结合因子 1 (LEF1) 和配对盒基因 8 (PAX8) 在区分这 2 个实体方面的效用。2007年1月至2016年8月在我院对细针抽吸细胞块和诊断为SPN或PanNET的手术切除标本进行LEF1和PAX8免疫组织化学检查。检查了8个SPN和25个PanNET细胞块以及17个SPN和34个PanNET手术切除标本. 在细胞块上,LEF1 阳性染色对 SPN 具有高频率、敏感性和特异性(88%、88%、和 88%)以及 PanNET 的 PAX8 阳性染色(76%、76% 和 75%)。手术切除标本的结果与细胞块的结果一致(SPN 中的 LEF1+:100%、100% 和 97%;PanNET 中的 PAX8+:59%、59% 和 100%)。组合 LEF1+/PAX8- 表型对 SPN(细胞块:63% 和 100%;手术标本:100% 和 98%)显示出高敏感性和特异性,PanNET 的 LEF1-/PAX8+ 表型(细胞块:64% 和100%;手术标本:59% 和 100%)。SPN 和 PanNET 表现出相反的免疫表型特征,SPN 中的 LEF1+/PAX8-和 PanNET 中的 LEF1-/PAX8+。这两种污渍的组合提供了区分这两种实体的有效方法。和 100%)。组合 LEF1+/PAX8- 表型对 SPN(细胞块:63% 和 100%;手术标本:100% 和 98%)显示出高敏感性和特异性,PanNET 的 LEF1-/PAX8+ 表型(细胞块:64% 和100%;手术标本:59% 和 100%)。SPN 和 PanNET 表现出相反的免疫表型特征,SPN 中的 LEF1+/PAX8-和 PanNET 中的 LEF1-/PAX8+。这两种污渍的组合提供了区分这两种实体的有效方法。和 100%)。组合的 LEF1+/PAX8- 表型对 SPN(细胞块:63% 和 100%;手术标本:100% 和 98%)显示出高敏感性和特异性,PanNET 的 LEF1-/PAX8+ 表型(细胞块:64% 和100%;手术标本:59% 和 100%)。SPN 和 PanNET 表现出相反的免疫表型特征,SPN 中的 LEF1+/PAX8-和 PanNET 中的 LEF1-/PAX8+。这两种污渍的组合提供了区分这两种实体的有效方法。
更新日期:2020-01-31
down
wechat
bug